Join
Live feed
·
PRReleasevia Quantisnow
Amgen Inc. logo
Zai Lab Limited logo

Zai Lab Announces Global Clinical Trial Collaboration and Supply Agreement to Evaluate Novel DLL3 ADC, Zocilurtatug Pelitecan, in Combination with a Bispecific T-cell Engager Therapy

ByQuantisnow·Wall Street's wire, on your screen.
AMGN· Amgen Inc.ZLAB· Zai Lab Limited
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AMGN (Amgen Inc.), ZLAB (Zai Lab Limited) and more on Quantisnow.